| Balance Sheets | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,383,848 | 932,711 | 521,944 | 426,361 |
| Accounts receivable, net of allowances of 24,611 and 22,424 at september30, 2025 and june30, 2025, respectively | 907,271 | 907,825 | 859,937 | 811,198 |
| Inventories (note 3) | 945,806 | 862,641 | 882,103 | 917,982 |
| Prepaid expenses and other current assets (note 3) | 388,811 | 505,243 | 572,193 | 485,584 |
| Total current assets | 3,625,736 | 3,208,420 | 2,836,177 | 2,641,125 |
| Property, plant and equipment, net (note 3) | 563,629 | 535,339 | 520,162 | 560,211 |
| Operating lease right-of-use assets | 162,007 | 152,603 | 151,012 | 157,068 |
| Goodwill (note 4) | 3,044,123 | 2,848,921 | 2,805,353 | 2,886,017 |
| Other intangible assets, net (note 3) | 447,067 | 430,109 | 438,003 | 478,613 |
| Deferred income taxes | 275,949 | 216,796 | 209,445 | 220,530 |
| Prepaid taxes and other non-current assets | 189,841 | 174,634 | 181,182 | 278,853 |
| Total non-current assets | 4,682,616 | 4,358,402 | 4,305,157 | 4,581,292 |
| Total assets | 8,308,352 | 7,566,822 | 7,141,334 | 7,222,417 |
| Accounts payable | 266,775 | 222,561 | 220,313 | 249,278 |
| Accrued expenses | 395,833 | 386,325 | 352,541 | 365,749 |
| Operating lease liabilities, current | 29,975 | 28,749 | 27,812 | 28,278 |
| Deferred revenue | 167,777 | 160,445 | 156,508 | 157,188 |
| Income taxes payable | 135,243 | 132,530 | 84,880 | 93,690 |
| Short-term debt, net (note 7) | 259,899 | 9,906 | 9,906 | 9,896 |
| Total current liabilities | 1,255,502 | 940,516 | 851,960 | 904,079 |
| Deferred revenue | 159,356 | 151,090 | 146,512 | 144,453 |
| Deferred income taxes | 77,571 | 78,983 | 77,004 | 83,521 |
| Operating lease liabilities, non-current | 147,817 | 137,991 | 139,159 | 144,490 |
| Other long-term liabilities | 138,181 | 48,983 | 10,831 | 83,270 |
| Long-term debt, net (note 7) | 408,661 | 663,126 | 662,859 | 667,578 |
| Total non-current liabilities | 931,586 | 1,080,173 | 1,036,365 | 1,123,312 |
| Total liabilities | 2,187,088 | 2,020,689 | 1,888,325 | 2,027,391 |
| Common stock, 0.004 par value, 350,000,000 shares authorized 190,390,128 issued and 145,940,669 outstanding at september30, 2025 and 190,311,097 issued and 146,385,350 outstanding at june30, 2025 | 762 | 761 | 760 | 758 |
| Additional paid-in capital | 2,062,244 | 1,990,137 | 1,957,359 | 1,924,584 |
| Retained earnings | 6,342,276 | 5,779,375 | 5,492,038 | 5,225,111 |
| Treasury stock, at cost, 44,448,959 shares at september30, 2025 and 43,925,747 shares at june30, 2025 | 2,223,302 | 1,973,284 | 1,898,258 | 1,823,272 |
| Accumulated other comprehensive loss | -60,716 | -250,856 | -298,890 | -132,155 |
| Total stockholders equity | 6,121,264 | 5,546,133 | 5,253,009 | 5,195,026 |
| Total liabilities and stockholders equity | 8,308,352 | 7,566,822 | 7,141,334 | 7,222,417 |
RESMED INC (RMD)
RESMED INC (RMD)